Hantavirus Tracker

18 U.S. passengers evacuated; 13 cases and three deaths from the Andes-linked cruise outbreak underscore immediate stakes and the virus's rare person-to-person transmission risk.

The stories trace a through-line between urgent containment — an HHS quarantine order overriding a CDC reviewer and the operational, state–federal and public-trust strains of a 42-day monitoring window — and a promising mitigation tool: a single-dose mRNA vaccine that fully protected hamsters in a 30-animal study with antibodies by day 14 and dose-sparing efficacy; watch federal-state enforcement outcomes, monitoring capacity and public trust, and whether the vaccine is advanced for outbreak or post-exposure use.

Tracking: hantavirus

Geography: United States (notably Four Corners / Southwest), Canada, Mexico, Central America, Chile, Argentina, Brazil, Bolivia, Paraguay, Uruguay, Europe (including Scandinavia, Balkans, Russia), China, Korea, Japan, Global / travel-associated cases

1. HHS Secretary orders hantavirus-exposed passenger to remain in federal quarantine

HHS Secretary Robert F. Kennedy Jr. ordered Angela Perryman to remain in federal quarantine at Nebraska Medical Center, overriding a CDC medical reviewer who recommended she return home under Florida’s once-daily telehealth monitoring.

Perryman, 47, had sought to leave earlier; Kennedy cited Florida’s refusal to meet federal monitoring requirements and extended the quarantine through June 21 while 18 U.S. passengers were evacuated to Nebraska for observation.

The group was exposed to Andes virus, an agent linked to three deaths and capable of rare person-to-person spread; one American tested positive and at least one other has mild symptoms.

The dispute highlights state–federal tension over quarantine enforcement, the operational burden on local public health, and risks to public trust during a 42-day monitoring period.

Key facts:

- Robert F. Kennedy Jr. extended federal quarantine through June 21.

- Angela Perryman, 47, remains in federal quarantine at Nebraska Medical Center.

- CDC medical reviewer Dr. Michael Bell recommended rescinding her federal quarantine.

- 18 U.S. passengers were evacuated to Nebraska for monitoring after exposure.

- Andes virus implicated; outbreak killed three people and can rarely transmit person-to-person.

Why it matters: The order exposes a sharp state–federal enforcement rift that can delay home-based monitoring, undermine public confidence, and invite legal scrutiny.

Operational consequences include immediate pressure on state and local health departments to accept strict continuous oversight or risk federal quarantine, while surveillance and timely case confirmation remain critical because Andes virus can rarely transmit between people and symptoms may appear within a 42-day window.

Mynbc5Livenowfox

2. Single-dose mRNA vaccine fully protected hamsters against Andes hantavirus

University of Texas Medical Branch researchers reported in The Lancet that a single mRNA vaccine dose completely protected animals against Andes hantavirus.

In a 30-hamster study, a single injection given four weeks before lethal exposure left every vaccinated animal symptom-free, with no replicating virus in tissues; antibodies were detectable within 14 days and protection persisted at 25, 5, and 1 mcg doses.

Andes virus is the only known hantavirus with documented person-to-person spread and caused a May 2026 cruise-ship outbreak (MV Hondius) with 13 reported cases and three deaths, dispersing nearly 150 passengers to 23 countries within a possible 42-day incubation window.

With inactivated hantavirus vaccines used in China and South Korea not protecting against Andes, and no hantavirus vaccines licensed by the FDA or EMA, the single-shot, dose-sparing results point to a candidate tool for rapid outbreak response and possible post-exposure use.

Key facts:

- Single mRNA dose fully protected hamsters against Andes hantavirus (UTMB study in The Lancet).

- Study used 30 hamsters; vaccine given once, four weeks before lethal exposure.

- Every vaccinated animal remained symptom-free and lacked replicating virus in tissues.

- Antibodies were detectable within 14 days post-vaccination.

- Protection held at 25, 5, and 1 mcg; 1 mcg generated antibodies in four of five animals.

Why it matters: If replicated in humans, single-dose, low-dose protection could enable rapid ring-vaccination and dose-sparing during Andes outbreaks, improving responses to person-to-person transmission events.

Key next steps to watch are human clinical trials, regulatory review, demonstrations of field effectiveness, and integration into regional outbreak response plans.

Gavi